Bing

Baxter Reports Record Sales, Earnings and Cash Flow for Full-Year 2012 Increased Investments in R&D and Business Development Set Strong... BAXTER DELIVERS SOLID FINANCIAL PERFORMANCE IN LINE WITH GUIDANCE FOR THIRD QUARTER …
Stockhouse · 9/1/2015
Freshly spun out from Baxter ($BAX), Baxalta has been busy creating a new research hub in Cambridge, MA, looking for new deals that will help it meet a goal of launching 20 new drugs by 2020. Baxalta execs pooh-poohed Shire's all-stock offer when it was ...
Fierce Biotech · ByJohn Carroll · 8/28/2015
Shire offer
BAX rose 1.75 percent to $38.33 ... Let's recap the trade itself. optionMONSTER® provides stock market insight, advanced options education, and actionable trade ideas to meet the needs of do-it-yourself investors. After spending decades in the trading ...
Option MONSTER · 8/27/2015
At the time, Shire said its $45.23-a-share all-stock takeover proposal was a 36pc premium ... Baxalta was spun-off from Baxter International (NYSE: BAX - news) on July 1 and Spire (Stuttgart: SIZ.SG - news) made its approach just nine days later.
Yahoo Finance UK and Ireland · 8/28/2015
I have been following Baxter International (NYSE:BAX) for some time now. I was very impressed with the dividend growth over the previous years. After the stock reached a new 52-week high, it began to sell off and had been floating around the $66.00 area ...
Seeking Alpha · 11/22/2013
BAX 855, a pegylated, full-length recombinant Factor VIII ... The researchers report employment and advisory roles with, research support and honoraria from, and stock ownership in Baxalta. Please see the full study for …
Healio · 9/1/2015
Other Factors Yet BAX’s high RSI value isn’t the only reason for investors to be concerned, as there has been some decidedly negative earnings estimate revisions in Baxter’s stock as of late. This is especially true when investors dive into some of ...
Yahoo Finance · 8/10/2015
Credit Suisse reiterated their hold rating on shares of Baxter International (NYSE:BAX) in a research report sent to investors on Monday, MarketBeat Ratings reports. Shares of Baxter International (NYSE:BAX) traded up 0.10% during midday trading on …
Mideast Times · 8/14/2015
[Business Wire] – Baxter International Inc. , announced today that its board of directors has approved the planned separation of its biopharmaceuticals business, which will be known as Baxalta Incorporated, and declared a special dividend distribution of ...
Jutia Group · 6/5/2015
Baxalta Inc (NYSE:BXLT)’s stock jumped by more than 15% after it reported positive phase three results for its underdevelopment drug BAX 111 and Shire PLC (ADR) (NASDAQ:SHPG)’s unsolicited bid for the biopharmaceutical firm. The journal of …
INSIDER MONKEY · 8/4/2015

Baxter International

Company
Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to tr…
Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. The company had 2013 sales of $15.3 billion, across two businesses: BioScience and Medical Products. Baxter’s BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine; and vaccines. Baxter’s Medical Products business produces intravenous solutions and other products used in the delivery of fluids and drugs to patients; inhalation anesthetics; contract manufacturing services; and products to …
Data from: Wikipedia